Single Vial Transport for Intestinal Parasites Launched
|
By LabMedica International staff writers Posted on 17 Jun 2015 |
|
Image: Trichuris trichiura (whipworm) ova from a stool specimen (Photo courtesy of the US Centers for Disease Control and Prevention).
A one-vial, multipurpose, transport solution for the collection, transportation, preservation and examination of intestinal parasites in stool specimens has been launched.
Traditional ova and parasite examination procedures, as well as fecal antigen immunoassay tests, require different types of preservatives/transports to run a complete parasitological examination.
The new transport medium allows laboratorians to perform all of the testing from one vial, a significant improvement over multi-vial systems. Stool specimens preserved in Para-Pak SVT (Meridian Bioscience, Inc.; Cincinnati, OH, USA) can be used for direct examination, concentration, permanent stain and will not interfere with fecal immunoassays. The new Para-Pak SVT (Single Vial Transport) is also mercury, polyvinyl-alcohol (PVA) and formalin free, a more eco-friendly alternative for the laboratories when it comes to handling and disposal. As experts in parasitology and leaders in pre-analytic collection systems, including stool collection and transport systems, Meridian Bioscience continues to develop innovative products that meet the needs of today's healthcare providers.
Michael C. Shaughnessy, Executive Vice President and President Meridian Global Diagnostics, said, “Over 20,000,000 stool transport systems are used in the USA annually and the development of Para-Pak SVT provides a simplified solution for healthcare providers by offering a one patient–one transport vial approach that helps reduce potential errors associated with traditional multi-vial systems, and also offers improved work-flow options for laboratories. This is a single transport system that is cost effective and adds testing flexibility to the lab, allowing them to perform from ova and parasite (O&P) examination and fecal immunoassays from one vial.”
Related Links:
Meridian Bioscience, Inc.
Traditional ova and parasite examination procedures, as well as fecal antigen immunoassay tests, require different types of preservatives/transports to run a complete parasitological examination.
The new transport medium allows laboratorians to perform all of the testing from one vial, a significant improvement over multi-vial systems. Stool specimens preserved in Para-Pak SVT (Meridian Bioscience, Inc.; Cincinnati, OH, USA) can be used for direct examination, concentration, permanent stain and will not interfere with fecal immunoassays. The new Para-Pak SVT (Single Vial Transport) is also mercury, polyvinyl-alcohol (PVA) and formalin free, a more eco-friendly alternative for the laboratories when it comes to handling and disposal. As experts in parasitology and leaders in pre-analytic collection systems, including stool collection and transport systems, Meridian Bioscience continues to develop innovative products that meet the needs of today's healthcare providers.
Michael C. Shaughnessy, Executive Vice President and President Meridian Global Diagnostics, said, “Over 20,000,000 stool transport systems are used in the USA annually and the development of Para-Pak SVT provides a simplified solution for healthcare providers by offering a one patient–one transport vial approach that helps reduce potential errors associated with traditional multi-vial systems, and also offers improved work-flow options for laboratories. This is a single transport system that is cost effective and adds testing flexibility to the lab, allowing them to perform from ova and parasite (O&P) examination and fecal immunoassays from one vial.”
Related Links:
Meridian Bioscience, Inc.
Gold Member
Collection and Transport System
PurSafe Plus®
Gold Member
Automated MALDI-TOF MS System
EXS 3000
New
Gold Member
Automatic CLIA Analyzer
Shine i9000
Latest Microbiology News
- Rapid Diagnostic Test Matches Gold Standard for Sepsis Detection
- Rapid POC Tuberculosis Test Provides Results Within 15 Minutes
- Rapid Assay Identifies Bloodstream Infection Pathogens Directly from Patient Samples
- Blood-Based Molecular Signatures to Enable Rapid EPTB Diagnosis
- 15-Minute Blood Test Diagnoses Life-Threatening Infections in Children
- High-Throughput Enteric Panels Detect Multiple GI Bacterial Infections from Single Stool Swab Sample
- Fast Noninvasive Bedside Test Uses Sugar Fingerprint to Detect Fungal Infections
- Rapid Sepsis Diagnostic Device to Enable Personalized Critical Care for ICU Patients
- Microfluidic Platform Assesses Neutrophil Function in Sepsis Patients
- New Diagnostic Method Confirms Sepsis Infections Earlier
- New Markers Could Predict Risk of Severe Chlamydia Infection
- Portable Spectroscopy Rapidly and Noninvasively Detects Bacterial Species in Vaginal Fluid
- CRISPR-Based Saliva Test Detects Tuberculosis Directly from Sputum
- Urine-Based Assay Diagnoses Common Lung Infection in Immunocompromised People
- Saliva Test Detects Implant-Related Microbial Risks
- New Platform Leverages AI and Quantum Computing to Predict Salmonella Antimicrobial Resistance
Channels
Clinical Chemistry
view channel
Chemical Imaging Probe Could Track and Treat Prostate Cancer
Prostate cancer remains a leading cause of illness and death among men, with many patients eventually developing resistance to standard hormone-blocking therapies. These drugs often lose effectiveness... Read more
Mismatch Between Two Common Kidney Function Tests Indicates Serious Health Problems
Creatinine has long been the standard for measuring kidney filtration, while cystatin C — a protein produced by all human cells — has been recommended as a complementary marker because it is influenced... Read more
Molecular Diagnostics
view channel
Simple Urine Test to Revolutionize Bladder Cancer Diagnosis and Treatment
Bladder cancer is one of the most common and deadly urological cancers and is marked by a high rate of recurrence. Diagnosis and follow-up still rely heavily on invasive cystoscopy or urine cytology, which... Read more
Blood Test to Enable Earlier and Simpler Detection of Liver Fibrosis
Persistent liver damage caused by alcohol misuse or viral infections can trigger liver fibrosis, a condition in which healthy tissue is gradually replaced by collagen fibers. Even after successful treatment... Read more
Hematology
view channel
Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk
Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more
Microvesicles Measurement Could Detect Vascular Injury in Sickle Cell Disease Patients
Assessing disease severity in sickle cell disease (SCD) remains challenging, especially when trying to predict hemolysis, vascular injury, and risk of complications such as vaso-occlusive crises.... Read more
ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners
Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read more
Immunology
view channel
New Test Distinguishes Vaccine-Induced False Positives from Active HIV Infection
Since HIV was identified in 1983, more than 91 million people have contracted the virus, and over 44 million have died from related causes. Today, nearly 40 million individuals worldwide live with HIV-1,... Read more
Gene Signature Test Predicts Response to Key Breast Cancer Treatment
DK4/6 inhibitors paired with hormone therapy have become a cornerstone treatment for advanced HR+/HER2– breast cancer, slowing tumor growth by blocking key proteins that drive cell division.... Read more
Chip Captures Cancer Cells from Blood to Help Select Right Breast Cancer Treatment
Ductal carcinoma in situ (DCIS) accounts for about a quarter of all breast cancer cases and generally carries a good prognosis. This non-invasive form of the disease may or may not become life-threatening.... Read more
Pathology
view channel
Tunable Cell-Sorting Device Holds Potential for Multiple Biomedical Applications
Isolating rare cancer cells from blood is essential for diagnosing metastasis and guiding treatment decisions, but remains technically challenging. Many existing techniques struggle to balance accuracy,... Read more
AI Tool Outperforms Doctors in Spotting Blood Cell Abnormalities
Diagnosing blood disorders depends on recognizing subtle abnormalities in cell size, shape, and structure, yet this process is slow, subjective, and requires years of expert training. Even specialists... Read more
Technology
view channel
Artificial Intelligence Model Could Accelerate Rare Disease Diagnosis
Identifying which genetic variants actually cause disease remains one of the biggest challenges in genomic medicine. Each person carries tens of thousands of DNA changes, yet only a few meaningfully alter... Read more
AI Saliva Sensor Enables Early Detection of Head and Neck Cancer
Early detection of head and neck cancer remains difficult because the disease produces few or no symptoms in its earliest stages, and lesions often lie deep within the head or neck, where biopsy or endoscopy... Read more
Industry
view channel
Abbott Acquires Cancer-Screening Company Exact Sciences
Abbott (Abbott Park, IL, USA) has entered into a definitive agreement to acquire Exact Sciences (Madison, WI, USA), enabling it to enter and lead in fast-growing cancer diagnostics segments.... Read more
